로딩 중…
지수 로딩 중…
Caris Life Sciences, Inc.
CAI· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$18.47+3.42%
2026-06-18
Price Chart
Caris Life Sciences, Inc.-34.04%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $5.22B |
| Revenue | $907M |
| Net Income | $34M |
| Total Assets | $1.16B |
| Net Assets | $593M |
| Value | |
| P/E | 153.64x |
| P/B | 8.80x |
| P/S | 5.75x |
| EV/EBITDA | 42.11x |
| FCF Yield | 2.36% |
| Profitability | |
| ROE | 5.73% |
| ROA | 2.92% |
| Op. Margin | 15.91% |
| Revenue Growth | 78.78% |
| Financial Health | |
| Debt Ratio | 95.86% |
| Total Debt | $173000.00 |
| FCF | $123M |
| Cash | $821M |
| Current Ratio | 7.05x |
| Net Debt/EBITDA | -7.86x |
| Performance | |
| 1Y Return | -34.04% |
| 1M Return | 23.46% |
| From 52W High | -56.54% |
| 1Y MDD | -62.98% |
| Trading | |
| Volume | 2,106,386 shares |
| Trading Value | $38M |
| Per Share | |
| EPS | $-0.04 |
| BPS | $0.35 |